Advertisement

Aptamere

  • C. KrügerEmail author
Chapter
Part of the Springer Reference Medizin book series (SRM)

Literatur

  1. Bunka DH, Stockley PG (2006) Aptamers come of age – at last. Nat Rev Microbiol 4(8):588–596PubMedCrossRefGoogle Scholar
  2. Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346:818–822PubMedPubMedCentralCrossRefGoogle Scholar
  3. Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR, Adamis AP (2006) Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov 5(2):123–132PubMedCrossRefGoogle Scholar
  4. Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505–510PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Euroimmun Medizinische Labordiagnostika AGLübeckDeutschland

Personalised recommendations